Tin tức & Cập nhật
Xem bài viết Nội tiết
Xem
Diabetes increases the risk of fracture among patients on kidney replacement therapy
Patients undergoing kidney replacement therapy appear to be at increased risk of developing a fracture in the presence of diabetes, a study has found.
Diabetes increases the risk of fracture among patients on kidney replacement therapy
30 Sep 2021
Low-carb diets may improve renal, CV risk factors in T2D patients
In individuals with type 2 diabetes (T2D), low-carbohydrate diets (LCDs) may improve renal and cardiovascular (CV) risk factors, suggests a review from the UK.
Low-carb diets may improve renal, CV risk factors in T2D patients
29 Sep 2021
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
In the treatment of patients with type 2 diabetes mellitus and hypertension, switching from a dipeptidyl peptidase-4 (DPP-4) inhibitor to the sodium-glucose cotransporter-2 (SGLT2) inhibitor luseogliflozin appears to have favourable effects on blood pressure (BP), circadian rhythm, and night-time systolic BP (SBP) and pulse rate (PR), according to data from the open-label LUNA trial.
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
28 Sep 2021
Side effects limit long-term therapy for primary aldosteronism
Long-term medical therapy in patients with primary aldosteronism (PA) is held back by dose-dependent side effects, according to a recent Singapore study.
